Dr. Tomayko is Vice President of Clinical Development at F2G, and is an expert in the Clinical Development of antibiotics with extensive experience in industry in key roles at Pfizer, Spero and GSK.
Current role
Member, Scientific Advisory Board at Tvardi Therapeutics
Member, Scientific Advisory Board at VasoRx
Member, Scientific Advisory Board at Prokaryotics
Member, Scientific Advisory Board at Prokaryotics
Member, Scientific Advisory Board at Prokaryotics